Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
The Food and Drug Administration on Friday granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.
The new pill is from Sage Therapeutics, which has a similar infused drug that’s given intravenously over three days in a medical facility. The FDA approved that drug in 2019, though it isn’t widely used because of its $34,000 price tag and the logistics of administering it. “I planned my pregnancies, I knew I wanted those kids but I didn’t want to interact with them,” said McMahon, who lives in New York City. She says her mood and outlook started improving within days of taking the first pills.Dr. Kimberly Yonkers of Yale University said the Zurzuvae effect is “strong” and the drug likely will be prescribed for women who haven’t responded to antidepressants. She wasn’t involved in testing the drug.
Sage did not immediately announce how it would price the pill, and Yonkers said that’ll be a key factor in how widely its prescribed.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
First-ever pill for postpartum depression is up for FDA approval this weekThe FDA is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression. If approved, it will become the first treatment that can be taken at home.
Baca lebih lajut »
First-ever pill for postpartum depression is up for FDA approval this weekThe Food and Drug Administration is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression.
Baca lebih lajut »
FDA warns some Tydemy birth control pills may not be effective, could result in unexpected pregnancyThe pills tested low for ascorbic acid, which could reduce their effectiveness and result in unwanted pregnancy, the FDA said.
Baca lebih lajut »
Batches of birth control pills recalled because they may have reduced effectiveness, FDA warnsLupin, the maker of Tydemy birth control pills, said it was recalling the drug due to reduced levels of ascorbic acid and an unidentified impurity.
Baca lebih lajut »
Thousands of Tydemy birth control pills recalled amid FDA efficacy concernsThe FDA warned consumers that almost 4,200 boxes of Tydemy, a birth control pill that was recalled last week, may have reduced effectiveness and could result in unexpected pregnancies.
Baca lebih lajut »
Recall alert: Birth control pills recalled; FDA says medication may be ‘ineffective’The FDA says the pills could be less effective in preventing pregnancy.
Baca lebih lajut »